First Broad Pharmacogenomics Test to Cancer Patients

Armen Hareyan's picture
Advertisement

Cancer Therapy

Mayo Clinic has validated and will offer to patients worldwide a test that enables its laboratory to determine through genetic screening which patients are likely to have a serious adverse reaction to irinotecan hydrochloride (Camptosar

Advertisement